Skip to main content
. 2021 Jun 29;19:3755–3764. doi: 10.1016/j.csbj.2021.06.038

Table 2.

Summary of odds ratios, Q statistics, I2 statistics for comorbidities.

Variable Studied No. of Studies Odds Ratio Q Statistic I2 statistic, %
Proportion of deceased with HTN 15/36 4.87 102.3 75.9
Proportion of survivors with HTN 9/36 82.1 93.8
Proportion of severe COVID-19 with HTN 18/36 3.26 202.2 93.9
Proportion of non-severe COVID-19 with HTN 14/36 830.9 98.8
Proportion of deceased with CVD 14/36 6.87 204.7 89.3
Proportion of survivors with CVD 8/36 53.2 93.6
Proportion of severe COVID-19 with CVD 19/36 3.16 431.3 95.8
Proportion of non-severe COVID-19 with CVD 15/36 832.9 98.9
Proportion of deceased with CBVD 8/36 4.28 17.9 64.9
Proportion of survivors with CBVD 5/36 17.6 82.8
Proportion of severe COVID-19 with CBVD 9/36 1.90 43.7 81.5
Proportion of non-severe COVID-19 with CBVD 7/36 22.8 84.4
Proportion of deceased with CKD 11/36 8.86 104.3 83.2
Proportion of survivors with CKD 5/36 4.9 0.0006
Proportion of severe COVID-19 with CKD 11/36 1.92 237.2 95.2
Proportion of non-severe COVID-19 with CKD 9/36 39.5 98.3

*Abbreviations used: HTN - hypertension; CVD - cardiovascular disease; CBVD - cerebrovascular disease; CKD - chronic kidney disease.